Cargando...

Venetoclax: evidence to date and clinical potential

The emergence of targeted therapy for patients with hematological diseases has permanently altered the therapeutic landscape. Immunochemotherapy regimes are now more and more being replaced by targeted therapies due to superior efficacy and better safety profiles. However, evolution and selection of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Drugs Context
Main Authors: Juárez-Salcedo, Luis Miguel, Desai, Viraj, Dalia, Samir
Formato: Artigo
Idioma:Inglês
Publicado: BioExcel Publishing Ltd 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6788387/
https://ncbi.nlm.nih.gov/pubmed/31645879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212574
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!